Weight-Loss drug wegovy could boost heart ablation success
Disease control
Recruiting now
This study tests whether taking semaglutide (Wegovy) for at least three months before a first-time atrial fibrillation ablation can improve heart rhythm outcomes. 200 overweight or obese adults scheduled for ablation will be randomly assigned to either standard care or semaglutid…
Phase 4 • Sponsor: Emma Svennberg • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC